Related Experiment Video
Updated: May 24, 2026
07:27
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
[BNP and NT-proBNP: reference values and cutoff limits].
J Teixeira1, M Guillaume, E Nellessen
1Service de Chimie Médicale, CHU de Liège, Belgique.
Revue Medicale De Liege
|March 17, 2012
Summary
Natriuretic peptides like BNP and NT-proBNP help rule out heart failure (HF) and assess risk. This study examines NT-proBNP reference values in Belgium to refine diagnostic cut-offs for HF screening.
Area of Science:
- Biomarkers in Cardiovascular Disease
- Clinical Chemistry
- Diagnostic Medicine
Context:
- Natriuretic peptides (BNP, NT-proBNP) are vital for screening heart failure (HF) symptoms.
- High negative predictive values enable confident exclusion of chronic HF, reducing unnecessary echocardiography.
- Elevated levels indicate increased risk of cardiovascular events and mortality.
Purpose:
- To discuss the delineation of decision limits for natriuretic peptides.
- To compare proposed cut-off limits with NT-proBNP reference values from a Belgian population.
- To analyze reference values considering age and gender influences.
Summary:
- Natriuretic peptide testing aids in excluding chronic heart failure (HF) and identifying high-risk patients.
- The study analyzes NT-proBNP reference values in the Liège area, Belgium.
- Age and gender significantly influence natriuretic peptide levels, impacting diagnostic interpretation.
Impact:
- Refining diagnostic cut-offs for natriuretic peptides can improve heart failure diagnosis accuracy.
- This research supports evidence-based clinical decision-making in cardiovascular risk stratification.
- Understanding population-specific reference values enhances the utility of natriuretic peptides in clinical practice.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:13Sensitivity, Specificity, and Predicted Value
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.